In addition, the loss of IGF2 imprinting was associated with esophageal adenocarcinoma [81], while the hypomethylation of one of the IGF2 promoters caused dysfunction in the transcriptional regulator Kruppel-like factor 4 (KLF4) in humane prostate cancer [82]. This evidence concerns the gene KLF4 and prostate cancer.